VANGUARD GROUP INC 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | Atea Pharmaceuticals, Inc. AVIR | VANGUARD GROUP INC | 4,599,710 5.510% | -1,489,812 (-24.47%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Atea Pharmaceuticals, Inc. AVIR | VANGUARD GROUP INC | 6,089,522 7.310% | 307,640 (+5.32%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | VANGUARD GROUP INC | 5,781,882 6.960% | 5,781,882 (New Position) | Filing |